Jason N. Butler
Stock Analyst at Citizens
(2.06)
# 2,967
Out of 5,163 analysts
17
Total ratings
43.75%
Success rate
-2.16%
Average return
Main Sectors:
Stocks Rated by Jason N. Butler
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ESPR Esperion Therapeutics | Maintains: Market Outperform | $4 → $5 | $2.44 | +104.92% | 1 | Mar 13, 2026 | |
| GHRS GH Research | Maintains: Market Outperform | $39 → $42 | $14.95 | +180.94% | 1 | Mar 6, 2026 | |
| ARGX argenx SE | Maintains: Market Outperform | $925 → $944 | $700.45 | +34.77% | 1 | Feb 27, 2026 | |
| IRWD Ironwood Pharmaceuticals | Maintains: Market Outperform | $8 → $10 | $3.37 | +196.74% | 1 | Feb 26, 2026 | |
| ACAD ACADIA Pharmaceuticals | Maintains: Market Outperform | $34 → $35 | $20.61 | +69.82% | 3 | Feb 26, 2026 | |
| ACHV Achieve Life Sciences | Initiates: Market Outperform | $19 | $4.17 | +355.64% | 1 | Nov 25, 2025 | |
| RAPP Rapport Therapeutics | Maintains: Market Outperform | $77 → $80 | $27.84 | +187.36% | 1 | Nov 7, 2025 | |
| WULF TeraWulf | Maintains: Market Outperform | $18 → $22 | $14.67 | +49.97% | 1 | Oct 29, 2025 | |
| RZLT Rezolute | Maintains: Market Outperform | $9 → $17 | $2.60 | +555.11% | 1 | Oct 29, 2025 | |
| ABVX ABIVAX Société Anonyme | Maintains: Market Outperform | $95 → $114 | $115.50 | -1.30% | 1 | Sep 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $22 | $6.45 | +241.09% | 1 | Sep 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Market Outperform | $78 | $60.06 | +29.88% | 1 | Sep 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $6 → $8 | $3.51 | +127.92% | 1 | Aug 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $19 → $18 | $9.98 | +80.36% | 1 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Outperform | $91 → $78 | $63.66 | +22.53% | 1 | Aug 6, 2025 |
Esperion Therapeutics
Mar 13, 2026
Maintains: Market Outperform
Price Target: $4 → $5
Current: $2.44
Upside: +104.92%
GH Research
Mar 6, 2026
Maintains: Market Outperform
Price Target: $39 → $42
Current: $14.95
Upside: +180.94%
argenx SE
Feb 27, 2026
Maintains: Market Outperform
Price Target: $925 → $944
Current: $700.45
Upside: +34.77%
Ironwood Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $8 → $10
Current: $3.37
Upside: +196.74%
ACADIA Pharmaceuticals
Feb 26, 2026
Maintains: Market Outperform
Price Target: $34 → $35
Current: $20.61
Upside: +69.82%
Achieve Life Sciences
Nov 25, 2025
Initiates: Market Outperform
Price Target: $19
Current: $4.17
Upside: +355.64%
Rapport Therapeutics
Nov 7, 2025
Maintains: Market Outperform
Price Target: $77 → $80
Current: $27.84
Upside: +187.36%
TeraWulf
Oct 29, 2025
Maintains: Market Outperform
Price Target: $18 → $22
Current: $14.67
Upside: +49.97%
Rezolute
Oct 29, 2025
Maintains: Market Outperform
Price Target: $9 → $17
Current: $2.60
Upside: +555.11%
ABIVAX Société Anonyme
Sep 25, 2025
Maintains: Market Outperform
Price Target: $95 → $114
Current: $115.50
Upside: -1.30%
Sep 9, 2025
Reiterates: Market Outperform
Price Target: $22
Current: $6.45
Upside: +241.09%
Sep 2, 2025
Reiterates: Market Outperform
Price Target: $78
Current: $60.06
Upside: +29.88%
Aug 19, 2025
Maintains: Market Outperform
Price Target: $6 → $8
Current: $3.51
Upside: +127.92%
Aug 13, 2025
Maintains: Market Outperform
Price Target: $19 → $18
Current: $9.98
Upside: +80.36%
Aug 6, 2025
Maintains: Market Outperform
Price Target: $91 → $78
Current: $63.66
Upside: +22.53%